Vaccines, Antibodies and Drug Libraries. The Possible COVID-19 Treatments Researchers Are Excited About
In early April, about four months after a new, highly infectious coronavirus was first identified in China, an international group of scientists reported encouraging results from a study of an experimental drug for treating the viral disease known as COVID-19. It was a small study, reported in the New England Journal of Medicine, but showed that remdesivir, an unapproved drug that was originally developed to fight Ebola, helped 68% of patients with severe breathing problems due to COVID-19 to improve; 60% of those who relied on a ventilator to breathe and took the drug were able to wean themselves off the machines after 18...
Source: TIME: Health - April 14, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Gabapentin for the Treatment of Hot Flushes in Menopause Gabapentin for the Treatment of Hot Flushes in Menopause
Is gabapentin a useful alternative to hormonal therapies for the treatment of vasomotor symptoms in postmenopausal women?Menopause (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 14, 2020 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

New Data Support Gabapentin for Alcohol Use Disorder New Data Support Gabapentin for Alcohol Use Disorder
The anticonvulsant gabapentin may help curb alcohol use and reduce withdrawal symptoms in patients with alcohol use disorder (AUD), new research suggests.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 11, 2020 Category: Neurology Tags: Psychiatry News Source Type: news

Gabapentin Seems Efficacious for Alcohol Use Disorder
Positive effect seen on heavy drinking days, total abstinence, especially in high alcohol withdrawal group (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - March 9, 2020 Category: Psychiatry Tags: Family Medicine, Internal Medicine, Emergency Medicine, Pharmacy, Psychiatry, Journal, Source Type: news

Gabapentin may ease withdrawal, improve abstinence in alcohol use disorder
The prescription drug Gabapentin may help those suffering from withdrawal symptoms during treatment for alcohol addiction, a new study has found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 9, 2020 Category: Consumer Health News Source Type: news

Gabapentin Seems Efficacious for Alcohol Use Disorder
MONDAY, March 9, 2020 -- Gabapentin appears to be efficacious for the treatment of alcohol use disorder (AUD), especially among those with high alcohol withdrawal, according to a study published online March 9 in JAMA Internal Medicine. Raymond F.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 9, 2020 Category: Pharmaceuticals Source Type: news

What Are Some Risk Factors for Cerebral Palsy?
Discussion The term, cerebral palsy, or CP has gone through many iterations with the first description in 1861 by W.J. Little who described it as “The condition of spastic rigidity of the limbs of newborn children.” The most recent definition is from Rosenbaun et al. in 2007 which states it is “a group of permanent disorders of the development of movement and posture, causing activity limitation, that are attributed to non-progressive disturbances that occurred in the developing fetal or infant brain. The motor disorders of cerebral palsy are often accompanied by disturbances of sensation, perception, cog...
Source: PediatricEducation.org - March 9, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

La FDA advierte acerca de problemas respiratorios graves con los medicamentos para convulsiones y dolor neural gabapentina (Neurontin, Gralise, Horizant) y pregabalina (Lyrica, Lyrica CR)
La Administraci ón de Alimentos y Medicamentos de EE. UU. (FDA) advierte que los pacientes con factores de riesgo respiratorio que usan gabapentina (Neurontin, Gralise, Horizant) o pregabalina (Lyrica, Lyrica CR) pueden sufrir graves dificultades respiratorias. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 30, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Withdrawal, dependence and adverse events of antidepressants: lessons from patients and data
Tolerability, withdrawal effects and dependence on prescription medication is an important topic of current scientific and clinical debate, as highlighted by the recent report published on September 2019 by Public Health England (https://www.gov.uk/government/publications/prescribed-medicines-review-report).1 This was a mixed methods public health review of available evidence in adults focusing on specific issues of dependence and withdrawal associated with five groups of medications: (1) benzodiazepines, (2) z-drugs, (3) gabapentin and pregabalin, (4) opioids and (5) antidepressants. The evidence included in the review co...
Source: Current Awareness Service for Health (CASH) - January 24, 2020 Category: Consumer Health News Source Type: news

Low-Dose Gabapentin in Combination with Methadone May Improve QOL in Patients with HNC
Administering a high dose of gabapentin also increased the percentage of patients who required no opioid during treatment, indicating that patients were possibly gleaning benefits from gabapentin in both treatment arms. (Source: CancerNetwork)
Source: CancerNetwork - January 23, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Study: Misuse of Certain Nonopioid Analgesics on the Rise
Research suggests that as the number of prescriptions written for opioids has dropped, there has been a corresponding rise in the use of nonopioid medications such as gabapentin and baclofen to treat certain types of pain. (Source: AAFP News)
Source: AAFP News - January 9, 2020 Category: Primary Care Source Type: news

FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR)
Listen to an audio podcast of the December 19, 2019 FDA Drug Safety Communication warning that serious breathing difficulties may occur in patients using seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR) who have respiratory risk factors. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 2, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Off-Label Use of Gabapentinoids: A New Paradigm
Several of the hot topics in geriatrics are pain management, medication reduction/deprescribing, and use of off-label medications. Best-practice use of gabapentinoids — gabapentin (Neurontin) and pregabalin (Lyrica) — comfortably fits into all three categories. Examination of the evidence may help health care practitioners make better decisions when prescribing these medications. (Source: Caring for the Ages)
Source: Caring for the Ages - December 25, 2019 Category: Health Management Authors: Daniel Haimowitz, Jeanne Manzi Source Type: news

Gabapentin, Opioids a Deadly Duo: FDA
The decision to order the new warnings is based on a review of data from numerous sources, including case reports, observational studies, human trials and animal studies. (Source: WebMD Health)
Source: WebMD Health - December 20, 2019 Category: Consumer Health News Source Type: news

FDA Warns of 'Serious' Problems With Gabapentin
FDA Warns of 'Serious' Respiratory Problems With Gabapentin (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 20, 2019 Category: General Medicine Source Type: news

Neurontin, Gralise, Horizant (gabapentin) and Lyrica, Lyrica CR (pregabalin): Drug Safety Communication - Serious Breathing Problems
FDA is warning that serious breathing difficulties may occur in patients using gabapentin or pregabalin who have respiratory risk factors. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 20, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Warns of'Serious' Respiratory Problems With Gabapentin FDA Warns of'Serious' Respiratory Problems With Gabapentin
The FDA is warning of serious, life-threatening respiratory problems associated with gabapentin.News Alerts (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - December 19, 2019 Category: Primary Care Tags: Neurology & Neurosurgery News Alert Source Type: news

Misuse of Nonopioid Medications Appears to Be on the Rise in U.S.
Increases seen for misuse/abuse, suicide attempts, and hospitalizations linked to gabapentin, baclofen (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - December 19, 2019 Category: Psychiatry Tags: Family Medicine, Internal Medicine, Emergency Medicine, Nursing, Pharmacy, Psychiatry, Anesthesiology & amp; Pain, Journal, Source Type: news

FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR)
Taking gabapentin or pregabalin with opioids, anxiety meds or antidepressants, or if you have lung issues or are elderly, can lead to serious breathing problems. Watch for breathing issues, confusion, dizziness, or extreme sleepiness. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 19, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Misuse of Nonopioid Medications Appears to Be on the Rise in U.S.
THURSDAY, Dec. 19, 2019 -- Misuse/abuse, use in suicide attempts, and hospital admissions associated with gabapentin and baclofen have significantly increased among U.S. adults since 2013, according to a study published online Dec. 1 in Clinical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 19, 2019 Category: Pharmaceuticals Source Type: news

Trends in gabapentin and baclofen exposures reported to U.S. poison centers - Reynolds K, Kaufman R, Korenoski A, Fennimore L, Shulman J, Lynch M.
Context: Prescriptions for nonopioid pharmacological therapies such as gabapentin and baclofen have been increasing. While gabapentin and baclofen are less likely than opioids to result in fatal overdose, they are each associated with dependence, mi... (Source: SafetyLit)
Source: SafetyLit - December 5, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

A common drug could help restore limb function after spinal cord injury
(Ohio State University) Long-term treatment with gabapentin, a commonly prescribed drug for nerve pain, could help restore upper limb function after a spinal cord injury, new research in mice suggests. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 3, 2019 Category: International Medicine & Public Health Source Type: news

Study highlights 'worrying' increase in misuse of non-opioid medications
(Taylor& Francis Group) A major new analysis of the non-opioid medications, gabapentin and baclofen, shows 'worrying' increases in related suicide attempts and hospital admissions in US adults since 2013 -- coinciding with a decrease in opioid prescriptions. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 2, 2019 Category: International Medicine & Public Health Source Type: news

New opioid library unveiled to help address epidemic
(Oregon Health& Science University) A new curated library provides a centralized toolkit for policymakers, patients and health care professionals working to address the nation's opioid epidemic. The site, funded through a settlement agreement involving the off-label marketing of the pain medication Neurontin, provides a single clearinghouse of actionable, evidence-based resources to address the epidemic. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 20, 2019 Category: International Medicine & Public Health Source Type: news

Early ID of prenatal exposure to opioids, gabapentin improves timely treatment of newborns
(Marshall University Joan C. Edwards School of Medicine) Timely identification of newborns exposed to both opioids and gabapentin during pregnancy could mean more appropriate care for newborns experiencing withdrawal. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2019 Category: International Medicine & Public Health Source Type: news

Steep Jump in Gabapentinoid Use Among US Patients With Cancer Steep Jump in Gabapentinoid Use Among US Patients With Cancer
The use of gabapentin and pregabalin doubled between 2005 and 2015 among US patients with cancer; experts say these drugs may be appropriate, but warn about adverse effects and potential for abuse.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 7, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Prescriptions for dangerously addictive opioids have almost DOUBLED in the past five years
There has been an 80 per cent increase in the number of prescriptions for powerful nerve drug gabapentin in England since 2013, a study has found. (Source: the Mail online | Health)
Source: the Mail online | Health - September 18, 2019 Category: Consumer Health News Source Type: news

Dishing out more drugs won ’t stop the pain. Doctors need new tools | Ann Robinson
As a GP, I know opioids have their place. But we shouldn ’t be complacent about a US-style crisis happening in BritainGrowing concern about the prescription of drugs that cause dependence has been backed up by a recent report from Public Health England (PHE). The agencydiscovered that in 2017-18, 13% of adults in England received at least one prescription for opioids such as morphine or oxycodone (although this represented a slight downturn in prescribing after a long upward trend). Other drug classes were implicated too, with 25% of adults prescribed one or more of the following drugs: benzodiazepines (such as Valiu...
Source: Guardian Unlimited Science - September 15, 2019 Category: Science Authors: Ann Robinson Tags: Opioids GPs NHS Doctors Health Society Drugs policy Politics Science UK news Source Type: news

gabapentin (Gralise) vs. duloxetine (Cymbalta)
Title: gabapentin (Gralise) vs. duloxetine (Cymbalta)Category: MedicationsCreated: 7/22/2019 12:00:00 AMLast Editorial Review: 7/22/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 22, 2019 Category: Drugs & Pharmacology Source Type: news

Industry Money Fuels Gabapentin Prescribing Industry Money Fuels Gabapentin Prescribing
Physicians who receive payments from makers of brand-name gabapentinoids are almost twice as likely to prescribe the brand-name agents vs generic versions, new research suggests.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - July 10, 2019 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news

More money, more gabapentin
Pharmaceutical companies' payments to doctors may be influencing them to prescribe more expensive, brand-name versions of the pain drug gabapentin, a team of researchers report in the July 8 issue of JAMA Internal Medicine, and the increasing use of the drug suggests it may be being abused. (Source: World Pharma News)
Source: World Pharma News - July 9, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Prescription rates for a painkiller linked to suicide TRIPLED as doctors received more kickbacks
Gabapentin is popular among US doctors because it doesn't interact with other drugs and it doesn't trigger a rush of ecstasy like other drugs. But it does have dangerous side effects. (Source: the Mail online | Health)
Source: the Mail online | Health - July 8, 2019 Category: Consumer Health News Source Type: news

DR ELLIE CANNON: My big toe pain is a huge problem
A 73-year-old patient has written to DR ELLIE CANNON about arthritis in her foot which is keeping her up at night. Her doctor has prescribed her a drug called gabapentin, but she's reluctant to take it. (Source: the Mail online | Health)
Source: the Mail online | Health - July 6, 2019 Category: Consumer Health News Source Type: news

Gabapentinoids used Off-label for Pain: Effective or Erroneous?
Off-label gabapentin and pregabalin prescribing for pain is widespread; the opioid crisis may be to blame. But does science support the trend? Find out with these 10 questions. (Source: ConsultantLive)
Source: ConsultantLive - June 21, 2019 Category: Internal Medicine Authors: Steven A. King, MD, MS Tags: Pain Source Type: news

Personal Health: Millions Take Gabapentin for Pain. But There ’ s Scant Evidence It Works.
“ There is very little data to justify how these drugs are being used and why they should be in the top 10 in sales, ” a researcher said. (Source: NYT Health)
Source: NYT Health - May 20, 2019 Category: Consumer Health News Authors: JANE E. BRODY Tags: Drugs (Pharmaceuticals) Gabapentin (Drug) Opioids and Opiates Neurontin (Drug) Drug Abuse and Traffic Pain-Relieving Drugs Source Type: news

Millions Take Gabapentin for Pain. But There ’s Scant Evidence It Works.
“There is very little data to justify how these drugs are being used and why they should be in the top 10 in sales,” a researcher said. (Source: NYT Health)
Source: NYT Health - May 20, 2019 Category: Consumer Health News Authors: Jane E. Brody Tags: Drugs (Pharmaceuticals) Gabapentin (Drug) Opioids and Opiates Neurontin (Drug) Drug Abuse and Traffic Pain-Relieving Drugs Source Type: news

Extended-release Gabapentin for Failed Back Surgery Syndrome Extended-release Gabapentin for Failed Back Surgery Syndrome
Is extended-release gabapentin efficacious for persistent pain after lumbar surgery?Pain (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - May 16, 2019 Category: Orthopaedics Tags: Neurology & Neurosurgery Journal Article Source Type: news

You asked: How to Stop a Hot Flash
Effective treatments are available to stop the discomfort of menopause symptoms. (Source: NYT Health)
Source: NYT Health - May 9, 2019 Category: Consumer Health News Authors: JEN GUNTER Tags: Menopause Estrogen Drugs (Pharmaceuticals) Women and Girls Gabapentin (Drug) Source Type: news

Gabapentin and Pregabalin for Pain in Children, Adolescents Gabapentin and Pregabalin for Pain in Children, Adolescents
What is the current evidence for the safety and efficacy of gabapentin and pregabalin for neuropathic and postoperative pain in children and adolescents?Anesthesia & Analgesia (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 5, 2019 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Rescheduling of gabapentin and pregabalin to Schedule 3 Controlled Drugs from 1 April 2019
Gabapentin and Pregabalin will be reclassified to Schedule 3 Controlled Drugs (CDs) from 1 April 2019. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 29, 2019 Category: Drugs & Pharmacology Source Type: news

Rescheduling of gabapentin and pregabalin to Schedule 3 Controlled Drugs from 1 April 2019
Gabapentin and pregabalin will be reclassified to Schedule 3 Controlled Drugs (CDs). This means from 1 April 2019: Prescriptions for gabapentin and pregabalin need to meet full prescription require (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - March 12, 2019 Category: Drugs & Pharmacology Source Type: news

Gabapentin Plus Opioids for Chronic Pain?
(MedPage Today) -- Small study shows no superiority over opioids alone (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 10, 2019 Category: Primary Care Source Type: news

Gralise (Gabapentin Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 25, 2019 Category: Drugs & Pharmacology Source Type: news

Pregabalin vs Gabapentin: A 10-question Quiz
Gabapentin and pregabalin have become popular alternatives to opioids for pain management. See what you  really know with our quick quiz.  (Source: ConsultantLive)
Source: ConsultantLive - February 14, 2019 Category: Internal Medicine Authors: Steven King, MD, MS Tags: Pain Source Type: news

Rescheduling of Gabapentin and Pregabalin to Schedule 3 Controlled Drugs from 1 April 2019
Gabapentin and Pregabalin will be reclassified to Schedule 3 Controlled Drugs (CDs). (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - February 13, 2019 Category: Drugs & Pharmacology Source Type: news

Trending gabapentin exposures in Kentucky after legislation requiring use of the state prescription drug monitoring program for all opioid prescriptions - Faryar KA, Webb AN, Bhandari B, Price TG, Bosse GM.
OBJECTIVE: Gabapentin is a gamma-aminobutyric acid (GABA) analog approved by the Food and Drug Administration (FDA) for partial seizures and post-herpetic neuralgia. Due to its wide therapeutic window and minimal adverse effects, it is frequently prescribe... (Source: SafetyLit)
Source: SafetyLit - January 29, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Q & A: When the Cat Needs a Painkiller
Owners have few good options for cats that need long-term relief. (Source: NYT Health)
Source: NYT Health - January 27, 2019 Category: Consumer Health News Authors: C. CLAIBORNE RAY Tags: Pain-Relieving Drugs Cats Cushing's Disease Gabapentin (Drug) Source Type: news

Gabapentin Improves Sexual Function in Some With Vulvodynia Gabapentin Improves Sexual Function in Some With Vulvodynia
Gabapentin improves sexual function in women with both vulvodynia and severe pelvic floor muscle pain.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 22, 2019 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Gabapentin Improves Sexual Function in Provoked Vulvodynia
MONDAY, Jan. 7, 2019 -- For women with provoked vulvodynia, gabapentin improves sexual function compared with placebo, although overall sexual function is still lower than for pain-free controls, according to a study published in the January issue... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 7, 2019 Category: Pharmaceuticals Source Type: news